Resources
35 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 1/23/2024 (updated 3/28/2024)
As RCORP Grantees continue to build and grow partnerships with Indigenous peoples and communities, further information is needed to support these partnerships through building trust, understanding community dynamics, and recognizing the importance of patient-centered care.
Posted 12/12/2023 (updated 3/28/2024)
Given the epidemic of increased maternal mortality and morbidity in the U.S., there is growing sentiment on how to mitigate preventable causes, including that of addressing substance use disorder (SUD). This webinar provided information on the complications of SUD in pregnancy, along with methods for effective intervention and management for clinicians and collaborators.
Posted 11/17/2023 (updated 3/28/2024)
Celebrate and honor the culture, traditions, and achievements of the nation's original inhabitants and of their descendants. The U.S Department of Health and Human Services (HHS) and the HHS Office of Minority Health (OMH) honor the history, culture, and legacy of Tribal nations and Indigenous communities across the United States.
Posted 11/6/2023 (updated 3/28/2024)
The John Hopkins Center for Indigenous Health launched the new Tribal Principles website which offers culturally relevant, Indigenous-centered guidance for Tribes to consider when creating spending plans for the use of Tribal opioid settlements. This work complements the broad state/national settlement guidance led at the Johns Hopkins Bloomberg School of Public Health.
Posted 8/25/2023 (updated 3/26/2024)
The National Institute for Health Care Management (NIHCM) provided interactive graphic reports on the trends in overdose deaths using the latest data. The interactive infographic shows the effects combined drugs, such as fentanyl and xylazine, have on overdoses.
Posted 7/31/2023 (updated 3/26/2024)
This presentation will cover health equity regarding rural American Indian and Alaska Native (AI/AN) communities' prevention and treatment efforts to address substance use disorder (SUD), including the need for contingency management for stimulants.
Posted 7/26/2023 (updated 3/28/2024)
As we look back over the past 3 years, stand in the present, and look forward, what emerging leadership approaches will create flourishing in our unique communities? This leadership inquiry encourages celebration, pondering of possibilities in good company, and consideration of leadership pivots.
Posted 7/26/2023 (updated 3/28/2024)
This session discussed the barriers typically encountered and workarounds such as money, staff, and location. We encouraged participants to bring successes, near successes, and non-successes in expanding access over the last 3 years.
Posted 7/14/2023 (updated 3/28/2024)
The Centers for Disease Control and Prevention released data showing a significant increase – 276 percent in 21 jurisdictions from 2019 to 2022 – in overdose deaths involving Xylazine, a nonopioid sedative that’s been detected in illicitly manufactured fentanyl drug products.
Posted 3/14/2023 (updated 3/27/2024)
Xylazine is a non-opioid that is approved for animals, and not FDA-approved for humans. New York State's Department of Health provides information on what it is, sources and trends, effects, why people use it, why clinicians should be concerned, and other information on Xylazine. Information about Xylazine is important to understand now that it has been showing up in illicit drug supply.